Document text
Principal Investigator: Wendy PrudhommeOMeara
Organization: DUKE UNIVERSITY
Fiscal Year: 2022
Award: $243,050
Funding agency: National Institute of Allergy and Infectious Diseases
In many developing countries, the Covid-19 pandemic has had limited direct impact, including Kenya, which as
of 5 March 2021, has recorded only 107,329 cases and 1,870 deaths owing to Covid19. Although this limited
clinical impact is in part the result of strict travel and movement restrictions and under-reporting, these low
numbers contrast with seroprevalences of 4-8% in Kenyan blood donors, suggesting that a large number of
Covid19 cases in Kenya are subclinical. A further consideration in such settings is the potential for interactions
between SARS-CoV2 and endemic pathogens such as Plasmodium falciparum, which in Western Kenya is
transmitted perennially and intensely. These asymptomatic infections shape the risk of subsequent malaria and
have differential impact on hosts. In this sero-epidemiologic study, our specific objective is to investigate the
spread of SARS-CoV2 in a large, densely-sampled community cohort in rural Kenya. Our longitudinal cohort
consists of Kenyan household members of all ages enrolled since January 2020 in an observational study of
malaria transmission in the rural district of Webuye (parent study R01 AI146849, MPI: O’Meara/Taylor). From
550 people, we have collected blood from all participants during both i) monthly surveillance visits as well as ii)
at febrile sick visits, and collection will be ongoing through 2023. The SARS-CoV2 antibody Prevalence and
Acquisition in Rural Kenya (SPARK) study will be a sub-study of this parent cohort, in which we will test
monthly specimens collected prior to and during the Covid19 pandemic using an ELISA detecting neutralizing
antibodies to the SARS-CoV2 spike protein. Baseline sero-positivity will be measured in Jan 2020 specimens,
and sero-conversion as the appearance of neutralizing antibodies in a previously-negative person. Monthly
questionnaires will capture recent travel and illness not previously reported to the study team. We will then,
using P. falciparum detection and genotype data from the parent study, estimate the impact of P. falciparum
infection on the risk of SARS-CoV2 acquisition using longitudinal statistical modelling of the effect of
cumulative malaria infections and of specific parasite genotypes on the risk of sero-conversion and the risk of
acute illness during sero-conversion. Our multidisciplinary team will use samples and data from a large,
separately-funded, densely-sampled longitudinal community cohort to describe the community spread and
sero-epidemiology of SARS-CoV2 in a rural Kenyan setting and investigate its associated with P. falciparum
malaria.
Terms: <2019 novel corona virus><2019 novel coronavirus><2019-nCoV><2019-nCoV S protein><2019-nCoV spike glycoprotein><2019-nCoV spike protein><Acute><Africa><African><Age><Appearance><Attenuated><Biological><Blood><Blood Reticuloendothelial System><Blood donor><COVID crisis><COVID epidemic><COVID pandemic><COVID-19><COVID-19 S protein><COVID-19 affected><COVID-19 antibody><COVID-19 consequence><COVID-19 crisis><COVID-19 effect><COVID-19 epidemic><COVID-19 global health crisis><COVID-19 global pandemic><COVID-19 health crisis><COVID-19 impact><COVID-19 impacted><COVID-19 pandemic><COVID-19 public health crisis><COVID-19 spike glycoprotein><COVID-19 spike protein><COVID-19 transmission><COVID-19 virus><COVID-19 virus transmission><COVID19><COVID19 S protein><COVID19 crisis><COVID19 epidemic><COVID19 global health crisis><COVID19 global pandemic><COVID19 health crisis><COVID19 pandemic><COVID19 public health crisis><COVID19 spike glycoprotein><COVID19 spike protein><COVID19 virus><CV-19><CV19><Cessation of life><Clinical><CoV-2><CoV2><Collection><Communicable Disease Contact Tracing><Communities><Contact Tracing><Country><Data><Death><Detection><Developing Countries><Developing Nations><ELISA><Enrollment><Enzyme-Linked Immunosorbent Assay><Epidemic><Epidemiology><Falciparum Malaria><Fever><Funding><Future><Genotype><Household><Immunomodulation><Infection><Infectious Disease Contact Tracing><Kenya><Less-Developed Countries><Less-Developed Nations><Long-term cohort><Long-term cohort study><Longitudinal cohort><Longitudinal cohort study><Longterm cohort><Longterm cohort study><Malaria><Measurable><Measures><Mediating><Morbidity><Morbidity - disease rate><Movement><Observation research><Observation study><Observational Study><Observational research><P falciparum><P. falciparum><P.falciparum><Paludism><Parasites><Parents><Participant><Persons><Phase><Plasmodium Infections><Plasmodium falciparum><Plasmodium falciparum Malaria><Population><Position><Positioning Attribute><Prevalence><Probabilistic Models><Probability Models><Pyrexia><Questionnaires><Reporting><Research Specimen><Risk><Risk Assessment><Risk Factors><Rural><SARS corona virus 2><SARS-CO-V2><SARS-COVID-2><SARS-CoV-2><SARS-CoV-2 S protein><SARS-CoV-2 antibody><SARS-CoV-2 epidemic><SARS-CoV-2 global health crisis><SARS-CoV-2 global pandemic><SARS-CoV-2 pandemic><SARS-CoV-2 spike glycoprotein><SARS-CoV-2 spike protein><SARS-CoV-2 transmission><SARS-CoV2><SARS-CoV2 S protein><SARS-CoV2 antibody><SARS-CoV2 epidemic><SARS-CoV2 pandemic><SARS-CoV2 spike glycoprotein><SARS-CoV2 spike protein><SARS-associated corona virus 2><SARS-associated coronavirus 2><SARS-coronavirus-2><SARS-coronavirus-2 epidemic><SARS-coronavirus-2 pandemic><SARS-related corona virus 2><SARS-related coronavirus 2><SARSCoV2><Sampling><Seroepidemiologic Studies><Seroepidemiological Study><Seroprevalences><Severe Acute Respiratory Coronavirus 2><Severe Acute Respiratory Distress Syndrome CoV 2><Severe Acute Respiratory Distress Syndrome Corona Virus 2><Severe Acute Respiratory Distress Syndrome Coronavirus 2><Severe Acute Respiratory Syndrome CoV 2><Severe Acute Respiratory Syndrome CoV 2 epidemic><Severe Acute Respiratory Syndrome CoV 2 pandemic><Severe Acute Respiratory Syndrome-associated coronavirus 2><Severe Acute Respiratory Syndrome-related coronavirus 2><Severe acute respiratory syndrome associated corona virus 2><Severe acute respiratory syndrome corona virus 2><Severe acute respiratory syndrome coronavirus 2><Severe acute respiratory syndrome coronavirus 2 S protein><Severe acute respiratory syndrome coronavirus 2 epidemic><Severe acute respiratory syndrome coronavirus 2 pandemic><Severe acute respiratory syndrome coronavirus 2 spike glycoprotein><Severe acute respiratory syndrome coronavirus 2 spike protein><Severe acute respiratory syndrome related corona virus 2><Severities><Shapes><Specimen><Statistical Models><Symptoms><Testing><Third-World Countries><Third-World Nations><Time><Transmission><Travel><Under-Developed Countries><Under-Developed Nations><Visit><Work><Wuhan coronavirus><ages><antibody against COVID-19><antibody against SARS-CoV-2><antibody against SARS-CoV2><antibody against coronavirus disease 2019><antibody against severe acute respiratory syndrome coronavirus 2><antibody to COVID-19><antibody to SARS-CoV-2><antibody to SARS-CoV2><antibody to coronavirus disease 2019><antibody to severe acute respiratory syndrome coronavirus 2><base><biologic><body movement><chronic infection><clinical epidemiology><co-infection><cohort><coinfection><community setting><community spread><community transmission><community-level spread><community-level transmission><corona virus disease 2019><corona virus disease 2019 epidemic><corona virus disease 2019 pandemic><coronavirus disease 2019><coronavirus disease 2019 S protein><coronavirus disease 2019 antibody><coronavirus disease 2019 consequence><coronavirus disease 2019 crisis><coronavirus disease 2019 effect><coronavirus disease 2019 epidemic><coronavirus disease 2019 global health crisis><coronavirus disease 2019 global pandemic><coronavirus disease 2019 health crisis><coronavirus disease 2019 impact><coronavirus disease 2019 pandemic><coronavirus disease 2019 public health crisis><coronavirus disease 2019 spike glycoprotein><coronavirus disease 2019 spike protein><coronavirus disease 2019 transmission><coronavirus disease 2019 virus><coronavirus disease 2019 virus transmission><coronavirus disease crisis><coronavirus disease epidemic><coronavirus disease pandemic><coronavirus disease-19><coronavirus disease-19 global pandemic><coronavirus disease-19 impact><coronavirus disease-19 pandemic><coronavirus disease-19 virus><coronavirus infectious disease-19><developing country><developing nation><enroll><enzyme linked immunoassay><epidemiologic><epidemiological><febrile><febris><hCoV19><immune modulation><immune regulation><immunologic reactivity control><immunomodulatory><immunoregulation><immunoregulatory><infection recurrence><insight><malaria infection><malaria transmission><malaria-infected><malarial infection><member><mortality><multidisciplinary><nCoV2><national surveillance><neutralizing antibody><pandemic><pandemic disease><pathogen><persistent infection><recurrent infection><seroconversion><seropositive><severe acute respiratory syndrome coronavirus 2 antibody><severe acute respiratory syndrome coronavirus 2 global health crisis><severe acute respiratory syndrome coronavirus 2 global pandemic><severe acute respiratory syndrome coronavirus 2 transmission><statistical linear mixed models><statistical linear models><transmission process><transmitted COVID-19><transmitted SARS-CoV-2><transmitted coronavirus disease 2019><transmitted severe acute respiratory syndrome coronavirus 2>